Environmental, Social And Governance (ESG) Report

Overview

The report describes InnoCare's first profitable year, approvals for two innovative drugs, commercial expansion, and progress toward a global biopharmaceutical platform. It documents a double-materiality assessment covering impact and financial materiality, with the resulting matrix reviewed by the Board. The report also adds 2025 Scope 3 disclosure, reporting total Scope 1, 2, and 3 greenhouse gas emissions of 49,589.36 tCO2e. Employee highlights include 52% female employees, zero work-related fatalities, and 100% employee health-examination coverage.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 25 March 2026
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview